Hughes DP - Search Results

1

Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia.

Irwin ME, Nelson LD, Santiago-O'Farrill JM, Knouse PD, Miller CP, Palla SL, Siwak DR, Mills GB, Estrov Z, Li S, Kornblau SM, Hughes DP, Chandra J. Irwin ME, et al. Among authors: hughes dp. PLoS One. 2013 Aug 1;8(8):e70608. doi: 10.1371/journal.pone.0070608. Print 2013. PLoS One. 2013. PMID: 23936456 Free PMC article.

2

Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis.

Hu J, Liu X, Hughes D, Esteva FJ, Liu B, Chandra J, Li S. Hu J, et al. PLoS One. 2011;6(8):e23270. doi: 10.1371/journal.pone.0023270. Epub 2011 Aug 10. PLoS One. 2011. PMID: 21853100 Free PMC article.

3

UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.

Zage PE, Sirisaengtaksin N, Liu Y, Gireud M, Brown BS, Palla S, Richards KN, Hughes DP, Bean AJ. Zage PE, et al. Among authors: hughes dp. Cancer. 2013 Feb 15;119(4):915-23. doi: 10.1002/cncr.27785. Epub 2012 Sep 18. Cancer. 2013. PMID: 22990745 Free PMC article.

4

Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.

Nikolova DA, Asangani IA, Nelson LD, Hughes DP, Siwak DR, Mills GB, Harms A, Buchholz E, Pilz LR, Manegold C, Allgayer H. Nikolova DA, et al. Among authors: hughes dp. Cancer Res. 2009 Mar 15;69(6):2461-70. doi: 10.1158/0008-5472.CAN-08-3236. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276367

5

Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer.

Nelson LD, Bender C, Mannsperger H, Buergy D, Kambakamba P, Mudduluru G, Korf U, Hughes D, Van Dyke MW, Allgayer H. Nelson LD, et al. Mol Cancer. 2012 Jun 8;11:38. doi: 10.1186/1476-4598-11-38. Mol Cancer. 2012. PMID: 22682314 Free PMC article.

6

Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.

Richards KN, Zweidler-McKay PA, Van Roy N, Speleman F, Trevino J, Zage PE, Hughes DP. Richards KN, et al. Among authors: hughes dp. Cancer. 2010 Jul 1;116(13):3233-43. doi: 10.1002/cncr.25073. Cancer. 2010. PMID: 20564646 Free PMC article.

7

Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition.

Hughes DP, Thomas DG, Giordano TJ, McDonagh KT, Baker LH. Hughes DP, et al. Pediatr Blood Cancer. 2006 May 1;46(5):614-23. doi: 10.1002/pbc.20454. Pediatr Blood Cancer. 2006. PMID: 16007579 Free article.

8

Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected].

Geryk-Hall M, Yang Y, Hughes DP. Geryk-Hall M, et al. Among authors: hughes dp. Mol Cancer Ther. 2010 May;9(5):1111-9. doi: 10.1158/1535-7163.MCT-09-0833. Epub 2010 Apr 20. Mol Cancer Ther. 2010. PMID: 20406948 Free PMC article.

9

Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions.

Geryk-Hall M, Hughes DP. Geryk-Hall M, et al. Among authors: hughes dp. Curr Oncol Rep. 2009 Nov;11(6):446-53. doi: 10.1007/s11912-009-0061-z. Curr Oncol Rep. 2009. PMID: 19840522

10

Understanding the role of Notch in osteosarcoma.

McManus MM, Weiss KR, Hughes DP. McManus MM, et al. Among authors: hughes dp. Adv Exp Med Biol. 2014;804:67-92. doi: 10.1007/978-3-319-04843-7_4. Adv Exp Med Biol. 2014. PMID: 24924169 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page